The molecular analysis of β-thalassemia mutations in Lorestan Province, Iran

被引:33
作者
Kiani, Ali Asghar
Mortazavi, Yousef
Zeinali, Sirous
Shirkhani, Yaghob
机构
[1] Zanjan Univ Med Sci, Fac Med, Dept Pathol, Zanjan, Iran
[2] Lorestan Univ Med Sci, Dept Hematol, Khorramabad, Iran
[3] Inst Pasteur, Dept Biotechnol, Tehran, Iran
关键词
beta-thalassemia (thal); amplification refractory mutation system-polymerase chain reaction (ARMS-PCR); mutation; Iran; Lorestan Province;
D O I
10.1080/03630260701459382
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-Thalassemia (thal) is one of the most common genetic disorders in Iran and other countries. Getting information on the distribution of mutations in different ethnic groups of Iran is of fundamental importance for the purpose of health planning and prenatal diagnosis programs. One hundred and thirty chromosomes from 65 unrelated homozygous beta-thal patients were investigated for)beta-globin gene mutations by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). The most common mutations of the Mediterranean region were examined in this study. Our results showed that the frameshift codons (MC) 36137 (-T) mutation, with a frequency of 33.8 %, is the most common mutation in Lorestan Province. The other most frequent mutations were of the Mediterranean type and consisted of IVS-II-1 (G -> A), IVS-I-110 (G -> A), MC 819 ((+)G) and IVS-I-5 (G -> C) with frequencies of 2 7.7, 11.5, 10.8 and 4.5 %, respectively. The less frequent alleles, IVS-II-745 (C -> G), MC 5 (-CT), IVS-I (25 bp deletion) and FSC 44 (-C accounted for only 3.9% of the mutations. The unknown alleles comprised 7.7% of the mutations. These data showed that the spectrum of mutations found in Lorestan Province was different from those reported from other thalassemic regions of Iran and also of some neighboring countries.
引用
收藏
页码:343 / 349
页数:7
相关论文
共 23 条
[1]   The β+-IVS-I-6 (T → C) mutation accounts for half of the thalassemia chromosomes in the Palestinian populations of the mountain regions [J].
Abd El-Latif, M ;
Filon, D ;
Rund, D ;
Oppenheim, A ;
Kanaan, M .
HEMOGLOBIN, 2002, 26 (01) :33-40
[2]   MOLECULAR CHARACTERIZATION OF ALPHA-THALASSEMIA DETERMINANTS, BETA-THALASSEMIA ALLELES, AND BETA(S) HAPLOTYPES AMONG KUWAITI ARABS [J].
ADEKILE, AD ;
GU, LH ;
BAYSAL, E ;
HAIDER, MZ ;
ALFUZAE, L ;
ABOOBACKER, KC ;
ALRASHIED, A ;
HUISMAN, THJ .
ACTA HAEMATOLOGICA, 1994, 92 (04) :176-181
[3]  
ATALAY EO, 1993, INT J HEMATOL, V57, P207
[4]   Impact of β globin gene mutations on the clinical phenotype of β thalassemia in India [J].
Colah, R ;
Nadkarni, A ;
Gorakshakar, A ;
Phanasgaonkar, S ;
Surve, R ;
Subramaniam, PG ;
Bondge, N ;
Pujari, K ;
Ghosh, K ;
Mohanty, D .
BLOOD CELLS MOLECULES AND DISEASES, 2004, 33 (02) :153-157
[5]  
DILMAGHANI S, 1997, P 6 INT C THAL HAEM, V29
[6]  
DILMAGHANI S, 1997, P 6 INT C THAL HAEM, V28
[7]   The frequency of 14 beta-thalassemia mutations in the Arab populations [J].
ElHazmi, MAF ;
Warsy, AS ;
AlSwailem, AR .
HEMOGLOBIN, 1995, 19 (06) :353-360
[8]  
Goossens M, 1981, Methods Enzymol, V76, P805
[9]  
Karimi M, 2004, MED SCI MONITOR, V10, pCR603
[10]   β-Thalassemia intermedia from Southern Iran:: IVS-II-1 (G→A) is the prevalent thalassemia intermedia allele [J].
Karimi, M ;
Yarmohammadi, H ;
Farjadian, S ;
Zeinali, S ;
Moghaddam, Z ;
Cappellini, MD ;
Giordano, PC .
HEMOGLOBIN, 2002, 26 (02) :147-154